Health Canada Approves Kane Biotech's Antimicrobial Wound Gel
2 reports, 1 independent
Updated Mon 00:00
Still developing
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Health Canada granted approval for revyve Antimicrobial Wound Gel and Antimicrobial Wound Gel Spray. Kane Biotech Inc. announced that the product has received both U.S. FDA 510(k) clearance and Health Canada approval.
From saultstar.com
Why it matters
The approval allows Kane Biotech Inc. to commercialize the product in Canada. The company plans to showcase the revyve product portfolio and present data at the Wounds Canada National Hybrid Conference.
Health Canada enforces regulatory requirements on products.
From saultstar.com
Who's involved
- Health CanadaGranted the regulatory approval for the antimicrobial wound gel
- companyDeveloped and commercializes the antimicrobial wound gel product
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.Keep exploring
The entities involved
-
Health Canada
Department of the Canadian Government that oversees public health
-
company
legal entity representing an association of people, whether natural, legal or a mixture of both, with a specific objective